Estrogen regulates Ah responsiveness in MCF-7 breast cancer cells

Carcinogenesis

Volumn 24, Issue 12, 2003, Pages 1941-1950

  Spink, David C ^a   Katz, Barbara H ^a   Hussain, Mirza M ^a   Pentecost, Brian T ^a   Cao, Zhimin ^a   Spink, Barbara C ^a  

^a WADSWORTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON; AROMATIC HYDROCARBON RECEPTOR; CARRIER PROTEIN; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ETHOXYRESORUFIN DEETHYLASE; LUCIFERASE; MESSENGER RNA; NUCLEAR PROTEIN;

ARTICLE; BREAST CARCINOGENESIS; CELL STRAIN MCF 7; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; ENZYME INDUCTION; ESTROGEN METABOLISM; GENE CONSTRUCT; GENETIC TRANSFECTION; HORMONE RESPONSE; HUMAN; HUMAN CELL; HYDROXYLATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE;

ACTIVE TRANSPORT, CELL NUCLEUS; ARYL HYDROCARBON HYDROXYLASES; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; CYTOCHROME P-450 CYP1A1; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; ESTROGENS; GENES, REPORTER; HUMANS; LUCIFERASES; RECEPTORS, ARYL HYDROCARBON; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFECTION;

EID: 0348149138     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgg162     Document Type: Article

References (66)

1. Shou,M., Korzekwa,K.R., Crespi,C.L., Gonzalez,F.J. and Gelboin,H.V. (1994) The role of 12 cDNA-expressed human, rodent, and rabbit cytochromes P450 in the metabolism of benzo[a]pyrene and benzo[a] pyrene trans-7,8-dihydrodiol. Mol. Carcinogen., 10, 159-168.
2. Shimada,T., Hayes,C.L., Yamazaki,H., Amin,S., Hecht,S.S., Guengerich,F.P. and Sutter,T.R. (1996) Activation of chemically diverse procarcinogens by human cytochrome P450 1B1. Cancer Res., 56, 2979-2984.
3. Einolf,H.J., Story,W.T., Marcus,C.B. et al. (1997) Role of cytochrome P450 enzyme induction in the metabolic activation of benzo[c]phenanthrene in human cell lines and mouse epidermis. Chem. Res. Toxicol., 10, 609-617.
4. Kim,J.H., Stansbury,K.H., Walker,N.J., Trush,M.A., Strickland,P.T. and Sutter,T.R. (1998) Metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-diol by human cytochrome P450 1B1. Carcinogenesis, 19, 1847-1853.
5. Spink,D.C., Eugster,H.P., Lincoln,D.W.,2nd, Schuetz,J.D., Schuetz,E.G., Johnson,J.A., Kaminsky,L.S. and Gierthy,J.F. (1992) 17β-Estradiol hydroxylation catalyzed by human cytochrome P450 1A1: a comparison of the activities induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in MCF-7 cells with those from heterologous expression of the cDNA. Arch. Biochem. Biophys., 293, 342-348.
6. Spink,D.C., Hayes,C.L., Young,N.R., Christou,M., Sutter,T.R., Jefcoate,C.R. and Gierthy,J.F. (1994) The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on estrogen metabolism in MCF-7 breast cancer cells: evidence for induction of a novel 17β-estradiol 4-hydroxylase. J. Steroid Biochem. Mol. Biol., 51, 251-258.
7. Hayes,C.L., Spink,D.C., Spink,B.C., Cao,J.Q., Walker,N.J. and Sutter,T.R. (1996) 17β-Estradiol hydroxylation catalyzed by human cytochrome P450 1B1. Proc. Natl Acad. Sci. USA, 93, 9776-9781.
8. Liehr,J.G., Fang,W.F., Sirbasku,D.A. and Ari-Ulubelen,A. (1986) Carcinogenicity of catechol estrogens in Syrian hamsters. J. Steroid Biochem., 24, 353-356.
9. Newbold,R.R. and Liehr,J.G. (2000) Induction of uterine adenocarcinoma in CD-1 mice by catechol estrogens. Cancer Res., 60, 235-237.
10. Devanesan,P., Todorovic,R., Zhao,J., Gross,M.L., Rogan,E.G. and Cavalieri,E.L. (2001) Catechol estrogen conjugates and DNA adducts in the kidney of male Syrian golden hamsters treated with 4-hydroxyestradiol: potential biomarkers for estrogen-initiated cancer. Carcinogenesis, 22, 489-497.
11. Liehr,J.G., Ricci,M.J., Jefcoate,C.R., Hannigan,E.V., Hokanson,J.A. and Zhu,B.T. (1995) 4-Hydroxylation of estradiol by human uterine myometrium and myoma microsomes: implications for the mechanism of uterine tumorigenesis. Proc. Natl Acad. Sci. USA, 92, 9220-9224.
12. Liehr,J.G. and Ricci,M.J. (1996) 4-Hydroxylation of estrogens as marker of human mammary tumors. Proc. Natl Acad. Sci. USA, 93, 3294-3296.
13. Yager,J.D. (2000) Endogenous estrogens as carcinogens through metabolic activation. J. Natl Cancer Inst. Monogr., 27, 67-73.
14. Larsen,M.C., Angus,W.G.R., Brake,P.B., Eltom,S.E., Sukow,K.A. and Jefcoate,C.R. (1998) Characterization of CYP1B1 and CYP1A1 expression in human mammary epithelial cells-role of the aryl hydrocarbon receptor in polycyclic aromatic hydrocarbon metabolism. Cancer Res., 58, 2366-2374.
15. Murray,G.I., Taylor,M.C., McFadyen,M.C., Mckay,J.A., Greenlee,W.F., Burke,M.D. and Melvin,W.T. (1997) Tumor-specific expression of cytochrome P450 CYP1B1. Cancer Res., 57, 3026-3031.
16. McFadyen,M.C., Cruickshank,M.E., Miller,I.D., McLeod,H.L., Melvin,W.T., Haites,N.E., Parkin,D. and Murray,G.I. (2001) Cytochrome P450 CYP1B1 over-expression in primary and metastatic ovarian cancer. Br. J. Cancer, 85, 242-246.
17. Chun,Y.J., Kim,S., Kim,D., Lee,S.K. and Guengerich,F.P. (2001) A new selective and potent inhibitor of human cytochrome P450 1B1 and its application to antimutagenesis. Cancer Res., 61, 8164-8170.
18. Ciolino,H.P., MacDonald,C.J and Yeh,G.C. (2002) Inhibition of carcinogen-activating enzymes by 16α-fluoro-5-androsten-17-one. Cancer Res., 62, 3685-3690.
19. Gu,Y.Z, Hogenesch,J.B. and Bradfield,C.A. (2000) The PAS superfamily: sensors of environmental and developmental signals. Annu. Rev. Pharmacol. Toxicol., 40, 519-561.
20. Shimizu,Y., Nakatsuru,Y., Ichinose,M., Takahashi,Y., Kume,H., Mimura,J., Fujii-Kuriyama,Y. and Ishikawa,T. (2000) Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor. Proc. Natl Acad. Sci. USA, 97, 779-782.
21. Whitlock,J.P.,Jr. (1999) Induction of cytochrome P4501A1. Annu. Rev. Pharmacol. Toxicol., 39, 103-125.
22. Kumar,M.B., Ramadoss,P., Reen,R.K., VandenHeuvel,J.P. and Perdew,G.H. (2001) The Q-rich subdomain of the human Ah receptor transactivation domain is required for dioxin-mediated transcriptional activity. J. Biol. Chem., 276, 42302-42310.
23. Beischlag,T.V., Wang,S., Rose,D.W., Torchia,J., Reisz-Porszasz,S., Muhammad,K., Nelson,W.E., Probst,M.R., Rosenfeld,M.G. and Hankinson,O. (2002) Recruitment of the NCoA/SRC-1/pl60 family of transcriptional coactivators by the aryl hydrocarbon receptor/aryl hydrocarbon receptor nuclear translocator complex. Mol. Cell. Biol., 22, 4319-4333.
24. Elbi,C., Misteli,T. and Hager,G.L. (2002) Recruitment of dioxin receptor to active transcription sites. Mol. Biol. Cell., 13, 2001-2015.
25. FitzGerald,C.T., Fernandez-Salguero,P., Gonzalez,F.J., Nebert,D.W. and Puga,A. (1996) Differential regulation of mouse Ah receptor gene expression in cell lines of different tissue origins. Arch. Biochem. Biophys., 333, 170-178.
26. Spink,B.C., Fasco,M.J., Gierthy,J.F. and Spink,D.C. (1998) 12-O-Tetradecanoylphorbol-13-acetate upregulates the Ah receptor and differentially alters CYP1A1 and CYP1B1 expression in MCF-7 breast cancer cells. J. Cell Biochem., 70, 289-296.
27. Garrison,P.M., Rogers,J.M., Brackney,W.R. and Denison,M.S. (2000) Effects of histone deacetylase inhibitors on the Ah receptor gene promoter. Arch. Biochem. Biophys., 374, 161-171.
28. 1. Mol. Pharmacol., 59, 716-724.
29. Vickers,P.J., Dufresne,M.J. and Cowan,K.H. (1989) Relation between cytochrome P450IA1 expression and estrogen receptor content of human breast cancer cells. Mol. Endocrinol., 3, 157-164.
30. Thomsen,J.S., Wang,X., Hines,R.N. and Safe,S. (1994) Restoration of aryl hydrocarbon (Ah) responsiveness in MDA-MB-231 human breast cancer cells by transient expression of the estrogen receptor. Carcinogenesis, 15, 933-937.
31. Spink,D.C., Spink,B.C., Cao,J.Q., DePasquale,J.A., Pentecost,B.T., Fasco,M.J., Li,Y. and Sutter,T.R. (1998) Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells. Carcinogenesis, 19, 291-298.
32. Angus,W.G.R., Larsen,M.C. and Jefcoate,C.R. (1999) Expression of CYP1A1 and CYP1B1 depends on cell-specific factors in human breast cancer cell lines: role of estrogen receptor status. Carcinogenesis, 20, 947-955.
33. Spink,D.C., Lincoln,D.W.,2nd, Dickerman,H.W. and Gierthy,J.F. (1990) 2,3,7,8-Tetrachlorodibenzo-p-dioxin causes an extensive alteration of 17β-estradiol metabolism in MCF-7 breast tumor cells. Proc. Natl Acad. Sci. USA, 87, 6917-6921.
34. Safe,S., Wormke,M. and Samudio,I. (2000) Mechanisms of inhibitory aryl hydrocarbon receptor-estrogen receptor crosstalk in human breast cancer cells. J. Mammary Gland Biol. Neoplasia, 5, 295-306.
35. Tian,Y., Ke,S., Thomas,T., Meeker,R.J. and Gallo,M.A. (1998) Transcriptional suppression of estrogen receptor gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). J. Steroid Biochem. Mol, Biol., 67, 17-24.
36. Rogers,J.M. and Denison,M.S. (2002) Analysis of the antiestrogenic activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in human ovarian carcinoma BG-1 cells. Mol. Pharmacol., 61, 1393-1403.
37. Spink,B.C., Katz,B.H., Hussain,M.M., Pang,S., Connor,S.P., Aldous,K.M., Gierthy,J.F. and Spink,D.C. (2000) SULT1A1 catalyzes 2-methoxyestradiol sulfonation in MCF-7 breast cancer cells. Carcinogenesis, 21, 1947-1957.
38. Donato,M.T., Gomez-Lechon,M.J. and Castell,J.V. (1993) A microassay for measuring cytochrome P450IA1 and P450IIB1 activities in intact human and rat hepatocytes cultured on 96-well plates. Anal. Biochem., 213, 29-33.
39. Laborda,J. (1991) 36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO. Nucleic Acids Res., 19, 3998.
40. Dolwick,K.M., Schmidt,J.V., Carver,L.A., Swanson,H.I. and Bradfield,C.A. (1993) Cloning and expression of a human Ah receptor cDNA. Mol. Pharmacol., 44, 911-917.
41. Abbott,B.D., Held,G.A., Wood,C.R., Buckalew,A.R., Brown,J.G. and Schmid,J. (1999) AhR, ARNT, and CYP1A1 mRNA quantitation in cultured human embryonic palates exposed to TCDD and comparison with mouse palate in vivo and in culture. Toxicol. Sci., 47, 62-75.
42. Barrow,L.L., Wines,M.E., Romitti,P.A., Holdener,B.C. and Murray,J.C. (2002) Aryl hydrocarbon receptor nuclear translocator 2 (ARNT2): structure, gene mapping, polymorphisms, and candidate evaluation for human orofacial clefts. Teratology, 66, 85-90.
43. Fasco,M.J., Treanor,C.P., Spivak,S., Figge,H.L. and Kaminsky,L.S. (1995) Quantitative RNA-polymerase chain reaction-DNA analysis by capillary electrophoresis and laser-induced fluorescence. Anal. Biochem., 224, 140-147.
44. Spink,B.C., Pang,S., Pentecost,B.T. and Spink,D.C. (2002) Induction of cytochrome P450 1B1 in MDA-MB-231 human breast cancer cells by non-ortho-substituted polychlorinated biphenyls. Toxicol. In Vitro, 16, 695-704.
45. Tang,Y.M., Wo,Y.-Y.P., Stewart,J., Hawkins,A.L., Griffin,C.A., Sutter,T.R. and Greenlee,W.F. (1996) Isolation and characterization of the human cytochrome P450 CYP1B1 gene. J. Biol. Chem., 271, 28324-28330.
46. Shehin,S.E., Stephenson,R.O. and Greenlee,W.F. (2000) Transcriptional regulation of the human CYP1B1 gene-evidence for involvement of an aryl hydrocarbon receptor response element in constitutive expression. J. Biol. Chem., 275, 6770-6776.
47. Shimada,T., Yamazaki,H., Foroozesh,M., Hopkins,N.E., Alworth,W.L. and Guengerich,F.P. (1998) Selectivity of polycyclic inhibitors for human cytochrome P450s 1A1, 1A2, and 1B1. Chem. Res. Toxicol., 11, 1048-1056.
48. Doostdar,H., Burke,M.D. and Mayer,R.T. (2000) Bioflavonoids: selective substrates and inhibitors for cytochrome P450 CYP1A1 and CYP1B1. Toxicology, 144, 31-38.
49. Pollenz,R.S. (1996) The aryl-hydrocarbon receptor, but not the aryl-hydrocarbon receptor nuclear translocator protein, is rapidly depleted in hepatic and nonhepatic culture cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Mol. Pharmacol., 49, 391-398.
50. Katzenellenbogen,B.S., Kendra,K.L., Norman,M.J. and Berthois,Y. (1987) Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens. Cancer Res., 47, 4355-4360.
51. Pink,J.J. and Jordan,V.C. (1996) Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines. Cancer Res., 56, 2321-2330.
52. Jeng,M.H., Shupnik,M.A., Bender,T.P., Westin,E.H., Bandyopadhyay,D., Kumar,R., Masamura,S. and Santen,R.J. (1998) Estrogen receptor expression and function in long-term estrogen-deprived human breast cancer cells. Endocrinology, 139, 4164-4174.
53. Kharat,I. and Saatcioglu,F. (1996) Antiestrogenic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin are mediated by direct transcriptional interference with the liganded estrogen receptor-cross-talk between aryl hydrocarbon- and estrogen-mediated signaling. J. Biol. Chem., 271, 10533-10537.
54. Ricci,M.S., Toscano,D.G., Mattingly,C.J. and Toscano,W.A. (1999) Estrogen receptor reduces CYP1A1 induction in cultured human endometrial cells. J. Biol. Chem., 274, 3430-3438.
55. Coumoul,X., Diry,M., Robillot,C. and Barouki,R. (2001) Differential regulation of cytochrome P450 1A1 and 1B1 by a combination of dioxin and pesticides in the breast tumor cell line MCF-7. Cancer Res., 61, 3942-3948.
56. Christou,M., Savas,Ü., Schroeder,S., Shen,X., Thompson,T., Gould,M.N. and Jefcoate,C.R. (1995) Cytochromes CYP1A1 and CYP1B1 in the rat mammary gland: cell-specific expression and regulation by polycyclic aromatic hydrocarbons and hormones. Mol. Cell. Endocrinol., 115, 41-50.
57. Morel,Y. and Barouki,R. (1998) Down-regulation of cytochrome P450 1A1 gene promoter by oxidative stress. Critical contribution of nuclear factor 1. J. Biol. Chem., 273, 26969-26976.
58. Kushner,P.J., Agard,D.A., Greene,G.L., Scanlan,T.S., Shiau,A.K., Uht,R.M. and Webb,P. (2000) Estrogen receptor pathways to AP-1. J. Steroid Biochem. Mol. Biol., 74, 311-317.
59. Porter,W., Saville,B., Hoivik,D. and Safe,S. (1997) Functional synergy between the transcription factor Sp1 and the estrogen receptor. Mol. Endocrinol., 11, 1569-1580.
60. Gierthy,J.F., Lincoln,D.W.,2nd, Roth,K.E., Bowser,S.S., Bennett,J.A., Bradley,L. and Dickerman,H.W. (1991) Estrogen-stimulation of postconfluent cell accumulation and foci formation of human MCF-7 cells. J. Cell. Biochem., 45, 177-187.
61. Pasqualini,J.R., Gelly,C., Nguyen,B.L. and Vella,C. (1989) Importance of estrogen sulfates in breast cancer. J. Steroid Biochem., 34, 155-163.
62. DiGiovanni,J., Berry,D.L., Gleason,G.L., Kishore,G.S. and Slaga,T.J. (1980) Time-dependent inhibition by 2,3,7,8-tetrachlorodibenzo-p-dioxin of skin tumorigenesis with polycyclic hydrocarbons. Cancer Res., 40, 1580-1587.
63. Vaziri,C., Schneider,A., Sherr,D.H. and Faller,D.V. (1996) Expression of the aryl hydrocarbon receptor is regulated by serum and mitogenic growth factors in murine 3T3 fibroblasts. J. Biol. Chem., 271, 25921-25927.
64. Trombino,A.F., Near,R.I., Matulka,R.A., Yang,S., Hafer,L.J., Toselli,P.A., Kim,D.W., Rogers,A.E., Sonenshein,G.E. and Sherr,D.H. (2000) Expression of the aryl hydrocarbon receptor/transcription factor (AhR) and AhR-regulated CYP1 gene transcripts in a rat model of mammary tumorigenesis. Breast Cancer Res. Treat., 63, 117-131.
65. Koliopanos,A., Kleeff,J., Xiao,Y., Safe,S., Zimmermann,A., Buchler,M.W. and Friess,H. (2002) Increased arylhydrocarbon receptor expression offers a potential therapeutic target for pancreatic cancer. Oncogene, 21, 6059-6070.
66. Khorram,O., Garthwaite,M. and Golos,T. (2002) Uterine and ovarian aryl hydrocarbon receptor (AHR) and aryl hydrocarbon receptor nuclear translocator (ARNT) mRNA expression in benign and malignant gynaecological conditions. Mol. Hum. Reprod., 8, 75-80.